BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22624634)

  • 1. Breaking up is hard to do: why disinvestment in medical technology is harder than investment.
    Haas M; Hall J; Viney R; Gallego G
    Aust Health Rev; 2012 May; 36(2):148-52. PubMed ID: 22624634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case studies that illustrate disinvestment and resource allocation decision-making processes in health care: a systematic review.
    Polisena J; Clifford T; Elshaug AG; Mitton C; Russell E; Skidmore B
    Int J Technol Assess Health Care; 2013 Apr; 29(2):174-84. PubMed ID: 23514665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring policy-makers' perspectives on disinvestment from ineffective healthcare practices.
    Elshaug AG; Hiller JE; Moss JR
    Int J Technol Assess Health Care; 2008; 24(1):1-9. PubMed ID: 18218163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disinvestment Activities and Candidates in the Health Technology Assessment Community: An Online Survey.
    Polisena J; Trunk G; Gutierrez-Ibarluzea I; Joppi R
    Int J Technol Assess Health Care; 2019 Jan; 35(3):189-194. PubMed ID: 31006390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of health technology assessment reports on decision making in Austria.
    Zechmeister I; Schumacher I
    Int J Technol Assess Health Care; 2012 Jan; 28(1):77-84. PubMed ID: 22233544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health economics and health technology assessment: perspectives from Australia and New Zealand.
    Streat S; Munn S
    Crit Care Clin; 2012 Jan; 28(1):125-33, vii. PubMed ID: 22123104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using health technology assessment to support optimal use of technologies in current practice: the challenge of "disinvestment".
    Henshall C; Schuller T; Mardhani-Bayne L
    Int J Technol Assess Health Care; 2012 Jul; 28(3):203-10. PubMed ID: 22792877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disinvestment in healthcare: a scoping review of systematic reviews.
    Kamaruzaman HF; Grieve E; Wu O
    Int J Technol Assess Health Care; 2022 Jul; 38(1):e69. PubMed ID: 35853843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reorienting programme budgeting and marginal analysis (PBMA) towards disinvestment.
    Mortimer D
    BMC Health Serv Res; 2010 Oct; 10():288. PubMed ID: 20942972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.
    Frønsdal KB; Facey K; Klemp M; Norderhaug IN; Mørland B; Røttingen JA
    Int J Technol Assess Health Care; 2010 Jul; 26(3):309-16. PubMed ID: 20584360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustainability in Health care by Allocating Resources Effectively (SHARE) 2: identifying opportunities for disinvestment in a local healthcare setting.
    Harris C; Allen K; King R; Ramsey W; Kelly C; Thiagarajan M
    BMC Health Serv Res; 2017 May; 17(1):328. PubMed ID: 28476159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximizing the clinical utility of comparative effectiveness research.
    Umscheid CA
    Clin Pharmacol Ther; 2010 Dec; 88(6):876-9. PubMed ID: 20962776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustainability in Health care by Allocating Resources Effectively (SHARE) 11: reporting outcomes of an evidence-driven approach to disinvestment in a local healthcare setting.
    Harris C; Allen K; Ramsey W; King R; Green S
    BMC Health Serv Res; 2018 May; 18(1):386. PubMed ID: 29843702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.